| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |